Jie Lv
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Inflammasome and immune disorders
- Circular RNAs in diseases
- Cancer-related gene regulation
Papers in
-
- Epigenetics and DNA Methylation 20
- RNA modifications and cancer 12
- Genomics and Chromatin Dynamics 12
- Cancer-related gene regulation 9
- Immunology 17
- Immune cells in cancer 6
- Co-authors
- Hui Che (7 shared papers)Yueqiu Wang (7 shared papers)Fan Yang (5 shared papers)Yunlong Bai (4 shared papers)Ying� Qin (4 shared papers)Qiong Wu (16 shared papers)Jianzhong Su (14 shared papers)Lihong Wang (3 shared papers)
- Journals
- Nucleic Acids Research (7 papers)Scientific Reports (3 papers)The Journal of Immunology (3 papers)PLoS ONE (3 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Jie Lv
99 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 723
- Molecular Biology 1.9k
- Physiology 111
- Nephrology 141
- Immunology 300
Countries citing papers authored by Jie Lv
This map shows the geographic impact of Jie Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Lv more than expected).
Fields of papers citing papers by Jie Lv
This network shows the impact of papers produced by Jie Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Lv. The network helps show where Jie Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy Hit paper breakdown → | 2019 | 355 |
| 2 | 2018 | 225 | |
| 3 | 2018 | 144 | |
| 4 | 2020 | 132 | |
| 5 | 2019 | 104 | |
| 6 | 2011 | 99 | |
| 7 | 2012 | 95 | |
| 8 | 2018 | 89 | |
| 9 | 2019 | 83 | |
| 10 | 2011 | 78 | |
| 11 | 2017 | 71 | |
| 12 | 2009 | 69 | |
| 13 | 2016 | 59 | |
| 14 | 2015 | 57 | |
| 15 | 2013 | 57 | |
| 16 | 2011 | 53 | |
| 17 | 2013 | 52 | |
| 18 | 2019 | 51 | |
| 19 | 2012 | 48 | |
| 20 | 2020 | 46 |
About Jie Lv
Jie Lv is a scholar working on Molecular Biology, Immunology, Cancer Research, Surgery and Oncology, having authored 107 papers that have together received 2.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (12 papers), Genomics and Chromatin Dynamics (12 papers), Cancer-related gene regulation (9 papers), Cytokine Signaling Pathways and Interactions (6 papers), Immune cells in cancer (6 papers) and Genetic Syndromes and Imprinting (5 papers). The work is most often cited by research in Cancer Research (723 citations), Molecular Biology (1.9k citations), Physiology (111 citations), Nephrology (141 citations) and Immunology (300 citations). Jie Lv has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hui Che, Yueqiu Wang, Fan Yang, Yunlong Bai, Ying� Qin, Qiong Wu, Jianzhong Su, Lihong Wang, Hongbo Liu and Yang Li. Their work appears in journals such as Nucleic Acids Research, Scientific Reports, The Journal of Immunology, PLoS ONE and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.